Treatment patterns and clinical outcomes of neoadjuvant chemoimmunotherapy for patients with resected oesophageal squamous cell carcinoma: a Chinese multicentre retrospective study.

Ther Adv Med Oncol · 2026 · PMC13129329 · PMID 42077606

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Two meta-analyses align with our findings, demonstrating that, while patients with LA-ESCC who received ⩾3 cycles of neoCIT presented higher MPR and pCR rates than those treated with 2 cycles did, these differences did not reach statistical significance. 16 This real-world cohort study found that patients who received ⩾3 cycles (vs ⩽2 cycles) of neoCIT had worse DFS.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.